Search research articles
Contact Us
Filters
Showing results (41-50 of 58) with videos related to
Page
of 6
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
January 3, 2023
Dystrophin myonuclear domain restoration governs treatment efficacy in dystrophic muscle
Adrien Morin, Amalia Stantzou, Olga N Petrova, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
June 27, 2014
Myostatin is a key mediator between energy metabolism and endurance capacity of skeletal muscle
Etienne Mouisel, Karima Relizani, Laurence Mille-Hamard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 28, 2014
Blockade of ActRIIB signaling triggers muscle fatigability and metabolic myopathy
Karima Relizani, Etienne Mouisel, Benoit Giannesini, et al.
Nature Medicine
|
February 3, 2015
Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers
Aurélie Goyenvalle, Graziella Griffith, Arran Babbs, et al.
Muscle & Nerve
|
October 7, 2021
Determinants of diaphragm inspiratory motion, diaphragm thickening, and its performance for predicting respiratory restrictive pattern in Duchenne muscular dystrophy
Abdallah Fayssoil, Lee S Nguyen, Tanya Stojkovic, et al.
Journal of Neuromuscular Diseases
|
December 20, 2018
Echographic Assessment of Diaphragmatic Function in Duchenne Muscular Dystrophy from Childhood to Adulthood
Abdallah Fayssoil, Cendrine Chaffaut, Adam Ogna, et al.
Journal of the American Heart Association
|
August 15, 2023
Prognosis of Right Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy
Abdallah Fayssoil, Nicolas Mansencal, Lee S Nguyen, et al.
Nature Communications
|
December 20, 2019
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7
Andreas Marg, Helena Escobar, Nikos Karaiskos, et al.
Neuromuscular Disorders : NMD
|
January 29, 2025
Safety and efficacy of tamoxifen in non-ambulant patients with Duchenne muscular dystrophy: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (TAMDMD Group B)
Bettina C Henzi, Niveditha Putananickal, Simone Schmidt, et al.
Neuromuscular Disorders : NMD
|
February 15, 2026
Safety and efficacy of tamoxifen in patients with duchenne muscular dystrophy: open label extension of TAMDMD trial
Gaëtan Zwingli, Niveditha Putananickal, Simone Schmidt, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 58) with videos related to
Sort By:
Page
of 6
Proceedings of the National Academy of Sciences of the United States of America
|
January 3, 2023
Dystrophin myonuclear domain restoration governs treatment efficacy in dystrophic muscle
Adrien Morin, Amalia Stantzou, Olga N Petrova, et al.
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
|
June 27, 2014
Myostatin is a key mediator between energy metabolism and endurance capacity of skeletal muscle
Etienne Mouisel, Karima Relizani, Laurence Mille-Hamard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
May 28, 2014
Blockade of ActRIIB signaling triggers muscle fatigability and metabolic myopathy
Karima Relizani, Etienne Mouisel, Benoit Giannesini, et al.
Nature Medicine
|
February 3, 2015
Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers
Aurélie Goyenvalle, Graziella Griffith, Arran Babbs, et al.
Muscle & Nerve
|
October 7, 2021
Determinants of diaphragm inspiratory motion, diaphragm thickening, and its performance for predicting respiratory restrictive pattern in Duchenne muscular dystrophy
Abdallah Fayssoil, Lee S Nguyen, Tanya Stojkovic, et al.
Journal of Neuromuscular Diseases
|
December 20, 2018
Echographic Assessment of Diaphragmatic Function in Duchenne Muscular Dystrophy from Childhood to Adulthood
Abdallah Fayssoil, Cendrine Chaffaut, Adam Ogna, et al.
Journal of the American Heart Association
|
August 15, 2023
Prognosis of Right Ventricular Systolic Dysfunction in Patients With Duchenne Muscular Dystrophy
Abdallah Fayssoil, Nicolas Mansencal, Lee S Nguyen, et al.
Nature Communications
|
December 20, 2019
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7
Andreas Marg, Helena Escobar, Nikos Karaiskos, et al.
Neuromuscular Disorders : NMD
|
January 29, 2025
Safety and efficacy of tamoxifen in non-ambulant patients with Duchenne muscular dystrophy: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial (TAMDMD Group B)
Bettina C Henzi, Niveditha Putananickal, Simone Schmidt, et al.
Neuromuscular Disorders : NMD
|
February 15, 2026
Safety and efficacy of tamoxifen in patients with duchenne muscular dystrophy: open label extension of TAMDMD trial
Gaëtan Zwingli, Niveditha Putananickal, Simone Schmidt, et al.
Page
of 6